Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M17.5Revenue $M1.1Net Margin (%)-1,296.0Altman Z-Score-16.4
Enterprise Value $M-0.8EPS $-1.8Operating Margin %-1,492.2Piotroski F-Score5
P/E(ttm)--Beneish M-Score-3.5Pre-tax Margin (%)-1,296.0Higher ROA y-yY
Price/Book1.310-y EBITDA Growth Rate %1.2Quick Ratio4.7Cash flow > EarningsY
Price/Sales11.85-y EBITDA Growth Rate %-25.7Current Ratio4.7Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-55.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-70.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M12.2ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with DCTH

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DCTHGeorge Soros 2011-03-31 Sold Out $98.88 - $183.04
($136.89)
$ 1.44-99%Sold Out0
DCTHGeorge Soros 2010-12-31 Add$115.2 - $180.32
($151.15)
$ 1.44-99%Add 7.14%1,312
DCTHGeorge Soros 2010-09-30 Buy $88.48 - $139.04
($113.58)
$ 1.44-99%New holding1,225
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DCTH is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


DCTH: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
APPLING WILLIAM MEVP, R&D and Global Operations 2013-06-25Sell0$0 view
APPLING WILLIAM MEVP, R&D and Global Operations 2013-06-25Sell0$0 view
LEUNG GABRIELDirector 2012-06-15Buy469$25.12-94.27 view
Koplewicz Harold SDirector 2012-06-01Buy4,167$23.84-93.96 view
Purpura JohnEVP Reg. Affairs/Quality Assur 2012-06-01Buy313$23.84-93.96 view
HOBBS EAMONN PPresident and CEO 2012-06-01Buy438$24.32-94.08 view
Simpson Jennifer K.Exec. VP, Global Marketing 2012-06-01Buy188$23.84-93.96 view
Philips Laura ADirector 2012-06-01Buy4,063$24.16-94.04 view
WATSON DOUGLAS GDirector 2012-06-01Buy3,125$24.16-94.04 view
Miao Graham GExec. V.P., CFO 2012-05-31Buy1,250$24-94 view

Press Releases about DCTH :

    Quarterly/Annual Reports about DCTH:

    News about DCTH:

    Articles On GuruFocus.com
    comment on DCTH Mar 15 2013 
    Weekly CFO Buys Highlight: BWEN, EMC, INO, DCTH, ACCO Jun 11 2012 
    cooldecency99 note on DCTH May 01 2010 
    cooldecency99 note on DCTH May 01 2010 
    Delcath Systems Inc. Reports Operating Results (10-Q) Oct 23 2009 

    More From Other Websites
    Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 May 29 2015
    9:01 am Delcath announces that positive Chemosat data will be highlighted at ASCO 2015 May 29 2015
    Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 May 29 2015
    Delcath's European Key Opinion Leader Forum On CHEMOSAT Therapy Affirms Benefits To Liver Cancer... May 27 2015
    Delcath's European Key Opinion Leader Forum On CHEMOSAT Therapy Affirms Benefits To Liver Cancer... May 27 2015
    DELCATH SYSTEMS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits May 26 2015
    Delcath Names Dr. Jennifer Simpson President And CEO May 26 2015
    Delcath Names Dr. Jennifer Simpson President And CEO May 26 2015
    ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open... May 21 2015
    ICC Cohort Of Delcath's Global Phase 2 Trial Of Melphalan/HDS In Hepatocellular Carcinoma Now Open... May 21 2015
    DELCATH SYSTEMS, INC. Financials May 20 2015
    10-Q for Delcath Systems, Inc. May 08 2015
    10-K for Delcath Systems, Inc. May 06 2015
    Delcath Reports 2015 First Quarter Financial Results May 06 2015
    DELCATH SYSTEMS, INC. Files SEC form 10-Q, Quarterly Report May 06 2015
    Delcath Reports 2015 First Quarter Financial Results May 06 2015
    Most active Nasdaq-traded stocks Apr 29 2015
    Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic... Apr 21 2015
    Delcath Receives Approval To Expand Global Phase 2 HCC Program To Include Patients With Intrahepatic... Apr 21 2015
    DELCATH SYSTEMS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Apr 14 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK